Invention Grant
- Patent Title: Anti-OX40L antibodies
-
Application No.: US12958278Application Date: 2010-12-01
-
Publication No.: US09102733B2Publication Date: 2015-08-11
- Inventor: Joseph Endl , Elsie M. Eugui , Maria Elena Fuentes , Yvo Graus , Aran Frank Labrijn , Martin Lanzendoerfer , Paul Parren , Frank Rebers , Ralf Schumacher , Stefan Seeber , Jan Van De Winkel , Martine Van Vugt
- Applicant: Joseph Endl , Elsie M. Eugui , Maria Elena Fuentes , Yvo Graus , Aran Frank Labrijn , Martin Lanzendoerfer , Paul Parren , Frank Rebers , Ralf Schumacher , Stefan Seeber , Jan Van De Winkel , Martine Van Vugt
- Applicant Address: US CA Palo Alto
- Assignee: Roche Palo Alto LLC
- Current Assignee: Roche Palo Alto LLC
- Current Assignee Address: US CA Palo Alto
- Agent Robert C. Hall
- Priority: EP04022158 20040917; EP04030546 20041223
- Main IPC: C07K16/28
- IPC: C07K16/28

Abstract:
This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from inflammatory diseases.
Public/Granted literature
- US20110070239A1 ANTI-OX40L ANTIBODIES Public/Granted day:2011-03-24
Information query